CA2075515C - Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor - Google Patents

Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor Download PDF

Info

Publication number
CA2075515C
CA2075515C CA002075515A CA2075515A CA2075515C CA 2075515 C CA2075515 C CA 2075515C CA 002075515 A CA002075515 A CA 002075515A CA 2075515 A CA2075515 A CA 2075515A CA 2075515 C CA2075515 C CA 2075515C
Authority
CA
Canada
Prior art keywords
msdna
msr
dna
retron
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002075515A
Other languages
English (en)
French (fr)
Other versions
CA2075515A1 (en
Inventor
Shohei Miyata
Atsushi Ohshima
Sumiko Inouye
Masayori Inouye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers Health
Original Assignee
University of Medicine and Dentistry of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of CA2075515A1 publication Critical patent/CA2075515A1/en
Application granted granted Critical
Publication of CA2075515C publication Critical patent/CA2075515C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002075515A 1991-08-30 1992-08-07 Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor Expired - Fee Related CA2075515C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/753,110 US5436141A (en) 1989-02-24 1991-08-30 Method for synthesizing stable single-stranded CDNA in eukaryotes by means of a bacterial retron and products
US07/753,110 1991-08-30

Publications (2)

Publication Number Publication Date
CA2075515A1 CA2075515A1 (en) 1993-03-01
CA2075515C true CA2075515C (en) 2005-11-01

Family

ID=25029201

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002075515A Expired - Fee Related CA2075515C (en) 1991-08-30 1992-08-07 Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor

Country Status (5)

Country Link
US (1) US5436141A (OSRAM)
EP (1) EP0532380B1 (OSRAM)
JP (1) JP3140206B2 (OSRAM)
CA (1) CA2075515C (OSRAM)
DE (1) DE69228098T2 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11866728B2 (en) 2022-01-21 2024-01-09 Renagade Therapeutics Management Inc. Engineered retrons and methods of use

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017737A (en) * 1989-02-24 2000-01-25 The University Of Medicine And Denistry Of New Jersey E. coli msDNA synthesizing system, products and uses
US5780269A (en) * 1989-02-24 1998-07-14 The University Of Medicine And Denistry Of New Jersey Hybrid molecules
US5849563A (en) * 1989-02-24 1998-12-15 The University Of Medecine And Dentistry Of New Jersey Eukaryotes expressing single stranded hybrid molecules
FR2675803B1 (fr) * 1991-04-25 1996-09-06 Genset Sa Oligonucleotides fermes, antisens et sens et leurs applications.
CA2151484A1 (en) 1992-12-09 1994-06-23 Jeffrey E. Miller Methods and compositions for cdna synthesis
US5366690A (en) * 1993-06-18 1994-11-22 Combustion Engineering, Inc. Zirconium alloy with tin, nitrogen, and niobium additions
US20070160581A1 (en) * 1994-04-29 2007-07-12 Cytogenix, Inc. Production of ssDNA in vivo
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO1999049029A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd Control of gene expression
JP2004503203A (ja) * 1998-10-09 2004-02-05 インジーン・インコーポレイテッド ＩＮＶＩＶＯでのｓｓＤＮＡの産生
IL142490A0 (en) * 1998-10-09 2002-03-10 Ingene Inc ENZYMATIC SYNTHESIS OF ssDNA
US20030082800A1 (en) * 1998-10-09 2003-05-01 Cytogenix, Inc. In vivo ssDNA expression vectors for altering gene expression
AU2004205192B2 (en) * 1998-10-09 2007-09-20 Cytogenix, Inc. Production of ssDNA in vivo
BR9914773A (pt) * 1998-10-09 2002-02-05 Ingene Inc Conjunto de elementos genéricos, método para a produção de dna de cordão único, transcrição de mrna, construção de ácido nucléico, transcrição de ssdna, vetor, sistema vetor, célula hospedeira, conjunto para a produção de uma sequência de ácido nucléico de cordão único, método para a produção in vivo ou in vitro de uma sequência de ácido nucléico de cordão único, transcrição de cdna de cordão único, ácido nucléico inibidor, molécula heteroduplex, e composição farmacêutica
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7419964B2 (en) * 1999-09-16 2008-09-02 Cytogenix, Inc. Treatment of HSV-related pathologies using ssDNA
AUPR621501A0 (en) 2001-07-06 2001-08-02 Commonwealth Scientific And Industrial Research Organisation Delivery of ds rna
EP2428568B1 (en) 2001-09-28 2018-04-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Microrna molecules
AU2011253686C1 (en) * 2001-09-28 2014-04-03 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Micro-RNA molecules
US20050260588A1 (en) * 2002-05-01 2005-11-24 Conrad Charles A In vivo ssdna expression vectors for altering gene expression
WO2003093424A2 (en) * 2002-05-01 2003-11-13 Cytogenix, Inc. In vivo ssdna expression vectors for altering gene expression
EP1517992B1 (en) * 2002-06-05 2013-08-21 Her Majesty the Queen in Right of Canada, as represented by the Minister of Agriculture and Agri-Food Retrons for gene targeting
US20050020526A1 (en) * 2003-06-03 2005-01-27 Cytogenix, Inc. Oligodeoxynucleotide intervention for prevention and treatment of sepsis
US20040248101A1 (en) * 2003-06-03 2004-12-09 Cytogenix, Inc. Identification of novel antibacteria agents by screening the single-stranded DNA expression library
IL273245B2 (en) 2017-09-15 2025-03-01 Commw Scient Ind Res Org RNA molecules
WO2023141602A2 (en) 2022-01-21 2023-07-27 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
WO2023183588A1 (en) * 2022-03-25 2023-09-28 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Methods of assessing engineered retron activity, and uses thereof
WO2024044723A1 (en) 2022-08-25 2024-02-29 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
WO2025081042A1 (en) 2023-10-12 2025-04-17 Renagade Therapeutics Management Inc. Nickase-retron template-based precision editing system and methods of use
WO2025117544A1 (en) 2023-11-29 2025-06-05 The Broad Institute, Inc. Engineered omega guide molecule and iscb compositions, systems, and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0132309A3 (en) * 1983-06-27 1985-12-27 The Board Of Trustees Of The Leland Stanford Junior University Novel regulatable eukaryotic promoter element
US5079151A (en) * 1989-02-24 1992-01-07 University Of Medicine And Dentistry Of New Jersey Production of branched RNA-linked multi-copy single-stranded DNA using permeabilized cells

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11866728B2 (en) 2022-01-21 2024-01-09 Renagade Therapeutics Management Inc. Engineered retrons and methods of use
US12054739B2 (en) 2022-01-21 2024-08-06 Renagade Therapeutics Management Inc. Engineered retrons and methods of use

Also Published As

Publication number Publication date
JP3140206B2 (ja) 2001-03-05
DE69228098T2 (de) 1999-07-01
JPH06217776A (ja) 1994-08-09
EP0532380A3 (OSRAM) 1994-05-04
DE69228098D1 (de) 1999-02-18
EP0532380A2 (en) 1993-03-17
CA2075515A1 (en) 1993-03-01
US5436141A (en) 1995-07-25
EP0532380B1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
CA2075515C (en) Method for synthesizing stable single-stranded cdna in eucaryotes by means of a bacterial retron, products and uses therefor
CN111647576B (zh) 一种热稳定性逆转录酶突变体及其应用
Driscoll et al. An in vitro system for the editing of apolipoprotein B mRNA
CN114410625B (zh) 通过Cas9-crRNA复合物的RNA指导的DNA裂解
CA2827948C (en) Use of template switching for dna synthesis
Najarian et al. DNA sequence and transcript mapping of MOD5: features of the 5′ region which suggest two translational starts
AU2020399673A1 (en) Antisense guide RNA with added functional region for editing target RNA
EP0530112B1 (en) Method for synthesizing singlestranded stem-loop DNAS
WO1993015096A1 (en) Cloning and expression of t5 dna polymerase reduced in 3'-to-5' exonuclease activity
JP2004517608A (ja) 分子クローニング法および使用試薬
Xuan et al. Overlapping reading frames at the LYS5 locus in the yeast Yarrowia lipolytica
Mason et al. Molecular cloning and characterization of the Candida albicans enolase gene
US5405775A (en) Retrons coding for hybrid DNA/RNA molecules
HUT62334A (en) Process for increasing thermus aquaticus dna-polymerase production in escherichia coli
WO1990010698A1 (en) Directional cloning
EP0562206B1 (en) Single-stranded DNA-RNA hybrid molecules and methods for their production
US5780269A (en) Hybrid molecules
US5849563A (en) Eukaryotes expressing single stranded hybrid molecules
Wang et al. The Mauriceville plasmid of Neurospora crassa: characterization of a novel reverse transcriptase that begins cDNA synthesis at the 3'end of template RNA
Singer et al. Cloning, purification, and properties of Candida albicans thymidylate synthase
McINTOSH et al. Transcriptional regulation of the cell cycle-dependent thymidylate synthase gene of Saccharomyces cerevisiae
Muchhal et al. Characterization of the unique intron-exon junctions of Euglena gene (s) encoding the polyprotein precursor to the light-harvesting chlorophyll a/b binding protein of photosystem II
EP0666313A2 (en) Targeting of telomerase in cancer gene therapy
CA2357540C (en) Method for producing an active heterodimeric amv-rt in prokaryotic cells
Gupta et al. Identification of two cis-acting elements that independently regulate the length of poly (A) on Xenopus albumin pre-mRNA

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed